Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 11.65
+0.13 (1.13%)
At close: Sep 5, 2025
SHE:301301 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Net Income | 1,089 | 1,400 | 940.56 | 411.52 | 111.35 | 229 | Upgrade |
Depreciation & Amortization | 578.43 | 558.47 | 550.11 | 547.73 | 524.05 | 491.29 | Upgrade |
Other Amortization | 0.88 | 0.88 | 0.99 | 1.32 | 0.66 | 0.53 | Upgrade |
Loss (Gain) From Sale of Assets | -0.35 | - | -1.34 | - | -0.26 | - | Upgrade |
Asset Writedown & Restructuring Costs | 22.67 | 1.25 | 1.28 | 31.5 | 16.82 | 1.41 | Upgrade |
Loss (Gain) From Sale of Investments | -0.72 | -0.36 | 4.57 | 3.76 | -3.89 | -2.08 | Upgrade |
Provision & Write-off of Bad Debts | -6.69 | -6.69 | 6.5 | - | - | 0.75 | Upgrade |
Other Operating Activities | 58.84 | 72.44 | 127.13 | 138.23 | 167.77 | 176.67 | Upgrade |
Change in Accounts Receivable | -85.33 | -557.51 | -274.69 | -424.19 | 78.13 | 163.01 | Upgrade |
Change in Inventory | -210.89 | 317.3 | -335.46 | 53.31 | -7.75 | -32.43 | Upgrade |
Change in Accounts Payable | -51.21 | -7.99 | 264.92 | -63.77 | -80.07 | -385.53 | Upgrade |
Change in Other Net Operating Assets | 12.49 | 12.49 | 17.9 | -3.46 | -0.66 | - | Upgrade |
Operating Cash Flow | 1,410 | 1,791 | 1,292 | 691.64 | 803.21 | 649.78 | Upgrade |
Operating Cash Flow Growth | 37.09% | 38.59% | 86.86% | -13.89% | 23.61% | - | Upgrade |
Capital Expenditures | -31.19 | -42.6 | -345.13 | -47.2 | -52.27 | -89.19 | Upgrade |
Sale of Property, Plant & Equipment | 0.05 | 0.05 | 0.02 | - | 0.77 | - | Upgrade |
Investment in Securities | -51.4 | -64.29 | - | -7 | 3.34 | - | Upgrade |
Other Investing Activities | 1.5 | 0.63 | -8.27 | - | - | 1.66 | Upgrade |
Investing Cash Flow | -81.05 | -106.22 | -353.37 | -54.2 | -48.16 | -87.53 | Upgrade |
Long-Term Debt Issued | - | 780 | 851.8 | 1,164 | 932.93 | 4,260 | Upgrade |
Long-Term Debt Repaid | - | -1,622 | -2,369 | -1,582 | -1,514 | -4,428 | Upgrade |
Net Debt Issued (Repaid) | -827.4 | -842.19 | -1,517 | -417.97 | -581.5 | -167.99 | Upgrade |
Issuance of Common Stock | 12.94 | 20.26 | - | 1,050 | - | - | Upgrade |
Common Dividends Paid | -632.78 | -545.07 | -290.12 | -142.82 | -167.8 | -57.26 | Upgrade |
Other Financing Activities | 5.93 | 5.93 | -1.07 | -13.42 | - | 6.65 | Upgrade |
Financing Cash Flow | -1,441 | -1,361 | -1,808 | 475.92 | -749.29 | -218.6 | Upgrade |
Foreign Exchange Rate Adjustments | 6.74 | 6.54 | 3.33 | 4.1 | -6.51 | -5.13 | Upgrade |
Net Cash Flow | -105.5 | 330.32 | -866.11 | 1,117 | -0.76 | 338.53 | Upgrade |
Free Cash Flow | 1,379 | 1,748 | 947.26 | 644.44 | 750.94 | 560.59 | Upgrade |
Free Cash Flow Growth | 85.79% | 84.58% | 46.99% | -14.18% | 33.96% | - | Upgrade |
Free Cash Flow Margin | 28.08% | 30.36% | 19.64% | 16.87% | 23.23% | 15.36% | Upgrade |
Free Cash Flow Per Share | 0.62 | 0.79 | 0.42 | 0.33 | 0.41 | 0.28 | Upgrade |
Cash Income Tax Paid | 642.98 | 648.47 | 529.02 | 283.66 | 134.55 | 174.51 | Upgrade |
Levered Free Cash Flow | 1,293 | 1,697 | 855.08 | 538.48 | 712.11 | 1,012 | Upgrade |
Unlevered Free Cash Flow | 1,324 | 1,736 | 909.94 | 627.44 | 822.66 | 1,121 | Upgrade |
Change in Working Capital | -331.81 | -235.25 | -337.42 | -442.41 | -13.29 | -247.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.